SQI appoints board member | S&P Global Market Intelligence

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
In PersonPolitics & Policy Live: Trade and Sustainability Amidst Volatile Markets
- 04/04/2023
- Convene, 1201 Wilson Blvd, Arlington, VA 22209
- 3:30 PM – 6:30 PM ET
WebinarThe Private Equity Landscape under review: The Middle East and Africa story in 2023
- 04/05/2023
- Live, Online
- 10:00 am - 11:00 am BST
WebinarManaging Investment Risk Amid Market Uncertainty
- 04/05/2023
- Live, Online
- 11:00 am - 12:00 am EST
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

SQI appoints board member

Perspectivas América Latina 2023 Emerging Trends & Growth

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

A Cloud Migration Plan for Corporations featuring Snowflake®

Investor Activism Campaigns Hit Record High in 2022

13 Jun, 2018 | 20:27

SQI appoints board member

Author Faizan Farooque
Theme Healthcare & Pharmaceuticals

Life sciences and diagnostics company SQI Diagnostics Inc. appointed Eric Zwisler to its board.

Zwisler most recently served as chairman of Cardinal Health China, a subsidiary of Cardinal Health Inc.

SQI Diagnostics develops and commercializes technologies and products for advanced microarray diagnostics.